At US$52.56, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?
May 17
Have your own idea? Try our Stock Screener
U.S. Healthtech Industry Analysis
UpdatedMay 19, 2025
DataAggregated Company Financials
Companies72
- 7D-2.2%
- 3M-10.0%
- 1Y6.4%
- YTDn/a
Over the last 7 days, the Healthtech industry has dropped 2.2%, driven by Doximity declining 14%. In the past year, the industry has gained 6.4%. Earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the U.S. Healthtech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 19 May 2025 | US$69.9b | US$13.1b | -US$1,460,873,518.00 | 54.4x | -47.9x | 5.3x |
| Wed, 16 Apr 2025 | US$66.8b | US$13.2b | -US$1,417,820,972.00 | 50.7x | -47.1x | 5.1x |
| Fri, 14 Mar 2025 | US$70.2b | US$13.2b | -US$1,417,465,589.00 | 56.7x | -49.5x | 5.3x |
| Sun, 09 Feb 2025 | US$76.7b | US$12.9b | -US$1,610,814,514.00 | 65.8x | -47.6x | 5.9x |
| Tue, 07 Jan 2025 | US$66.3b | US$12.9b | -US$1,636,336,735.00 | 55.3x | -40.5x | 5.1x |
| Thu, 05 Dec 2024 | US$67.5b | US$12.8b | -US$1,712,780,390.00 | 60.3x | -39.4x | 5.3x |
| Sat, 02 Nov 2024 | US$62.3b | US$13.5b | -US$3,010,457,656.00 | 49x | -20.7x | 4.6x |
| Mon, 30 Sep 2024 | US$65.2b | US$14.0b | -US$3,288,675,208.00 | 53.5x | -19.8x | 4.7x |
| Wed, 28 Aug 2024 | US$63.1b | US$13.9b | -US$3,379,735,604.00 | 58.4x | -18.7x | 4.5x |
| Fri, 26 Jul 2024 | US$58.7b | US$13.7b | -US$1,860,658,542.00 | 51.6x | -31.5x | 4.3x |
| Sun, 23 Jun 2024 | US$57.2b | US$13.7b | -US$1,889,788,216.00 | 47.3x | -30.3x | 4.2x |
| Tue, 21 May 2024 | US$59.1b | US$12.8b | -US$1,973,252,856.00 | 46.9x | -29.9x | 4.6x |
| Thu, 18 Apr 2024 | US$57.3b | US$12.7b | -US$1,620,331,315.00 | 48.2x | -35.4x | 4.5x |
| Sat, 16 Mar 2024 | US$64.8b | US$14.3b | -US$1,457,126,316.00 | 48.8x | -44.5x | 4.5x |
| Mon, 12 Feb 2024 | US$63.6b | US$13.8b | -US$5,675,716,752.00 | 61.6x | -11.2x | 4.6x |
| Wed, 10 Jan 2024 | US$71.5b | US$18.3b | -US$5,780,492,665.00 | 54.8x | -12.4x | 3.9x |
| Fri, 08 Dec 2023 | US$66.7b | US$18.3b | -US$5,772,419,665.00 | 52.6x | -11.6x | 3.6x |
| Sun, 05 Nov 2023 | US$68.0b | US$18.3b | -US$5,826,818,376.00 | 52x | -11.7x | 3.7x |
| Tue, 03 Oct 2023 | US$70.0b | US$18.0b | -US$5,559,240,965.00 | 52.1x | -12.6x | 3.9x |
| Thu, 31 Aug 2023 | US$71.1b | US$17.9b | -US$5,546,705,389.00 | 50.9x | -12.8x | 4x |
| Sat, 29 Jul 2023 | US$77.7b | US$17.8b | -US$5,538,206,318.00 | 62.2x | -14x | 4.4x |
| Mon, 26 Jun 2023 | US$75.2b | US$17.7b | -US$8,580,509,261.00 | 62x | -8.8x | 4.2x |
| Wed, 24 May 2023 | US$69.3b | US$17.7b | -US$8,622,664,320.00 | 58.3x | -8x | 3.9x |
| Fri, 21 Apr 2023 | US$74.8b | US$17.4b | -US$14,978,330,855.00 | 59.2x | -5x | 4.3x |
| Sun, 19 Mar 2023 | US$71.2b | US$17.7b | -US$15,404,092,855.00 | 52.6x | -4.6x | 4x |
| Tue, 14 Feb 2023 | US$72.9b | US$17.5b | -US$10,822,839,563.00 | 53.7x | -6.7x | 4.2x |
| Thu, 12 Jan 2023 | US$69.9b | US$17.5b | -US$10,803,491,310.00 | 45.3x | -6.5x | 4x |
| Sat, 10 Dec 2022 | US$72.0b | US$17.5b | -US$10,606,433,310.00 | 49.8x | -6.8x | 4.1x |
| Mon, 07 Nov 2022 | US$66.6b | US$17.4b | -US$10,579,915,342.00 | 32.9x | -6.3x | 3.8x |
| Wed, 05 Oct 2022 | US$73.7b | US$17.1b | -US$10,593,627,342.00 | 32.5x | -7x | 4.3x |
| Fri, 02 Sep 2022 | US$75.5b | US$17.0b | -US$10,549,847,342.00 | 33.5x | -7.2x | 4.4x |
| Sun, 31 Jul 2022 | US$95.6b | US$17.5b | -US$10,943,133,542.00 | 46.9x | -8.7x | 5.5x |
| Tue, 28 Jun 2022 | US$121.9b | US$23.2b | -US$7,415,282,621.00 | 53x | -16.4x | 5.2x |
| Thu, 26 May 2022 | US$111.9b | US$23.1b | -US$7,379,417,621.00 | 48.3x | -15.2x | 4.8x |
Price to Earnings Ratio
-15.2x
Current Industry PE
- Investors are optimistic on the American Health Care Technology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.5x is lower than the industry's current PS ratio of 5.3x.
Past Earnings Growth
- The earnings for companies in the Health Care Technology industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 17% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Comparison
How does U.S. Healthtech compare with similar industries?
| US Market | 2.94% | |
| Healthcare | -1.42% | |
| Healthtech | -2.20% | |
| Healthtech | -2.20% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| VEEV Veeva Systems | US$242.78 | 0.6% +US$218.4m | 15.6% | PE55.4x | |
| LFMD LifeMD | US$10.72 | 25.4% +US$98.6m | 35.7% | PS2.1x | |
| CTEV Claritev | US$27.38 | 25.5% +US$91.6m | 25.3% | PS0.5x | |
| OPRX OptimizeRx | US$11.43 | 24.2% +US$41.3m | -12.6% | PS2.2x | |
| HSTM HealthStream | US$28.49 | 3.8% +US$31.7m | 3.6% | PE45.5x |
